A better buy-in window may exist right now for Amicus Therapeutics Inc (FOLD)

With 5.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.39 million shares. The 52-week range on FOLD shows that it touched its highest point at $12.65 and its lowest point at $6.20 during that stretch. It currently has a 1-year price target of $15.82. Beta for […]
This trade activity should not be overlooked: Amicus Therapeutics Inc (FOLD)

With 4.27 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.96 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $7.41 whereas the lowest price it dropped to was $7.26. The 52-week range on FOLD shows […]
Amicus Therapeutics Inc (FOLD) expanding its growth trajectory ahead

With 2.75 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.8 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $6.915 whereas the lowest price it dropped to was $6.66. The 52-week range on FOLD shows […]
A look into Amicus Therapeutics Inc (FOLD)’s deeper side

With 3.31 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.74 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $6.92 whereas the lowest price it dropped to was $6.65. The 52-week range on FOLD shows […]
Amicus Therapeutics Inc (FOLD) expanding its growth trajectory ahead

With 4.77 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.47 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $8.06 whereas the lowest price it dropped to was $7.72. The 52-week range on FOLD shows […]
Check out these key findings about Amicus Therapeutics Inc (FOLD)

With 2.72 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.31 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $8.67 whereas the lowest price it dropped to was $8.4. The 52-week range on FOLD shows […]
Is Amicus Therapeutics Inc (FOLD) positioned for future growth?

With 1.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.24 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $9.2551 whereas the lowest price it dropped to was $9.07. The 52-week range on FOLD shows […]
Its Stock Has Paid Off Big Time For Amicus Therapeutics Inc

With 2.42 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.33 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $9.0 whereas the lowest price it dropped to was $8.795. The 52-week range on FOLD shows […]
Take off with Amicus Therapeutics Inc (FOLD): Get ready for trading

With 1.98 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.48 million shares. The 52-week range on FOLD shows that it touched its highest point at $13.49 and its lowest point at $8.78 during that stretch. It currently has a 1-year price target of $16.73. Beta for […]